These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6497571)

  • 1. Abnormal results of dexamethasone suppression tests in nondepressed patients with diabetes mellitus.
    Hudson JI; Hudson MS; Rothschild AJ; Vignati L; Schatzberg AF; Melby JC
    Arch Gen Psychiatry; 1984 Nov; 41(11):1086-9. PubMed ID: 6497571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypothalamic-pituitary-adrenocortical activity in patients with diabetes mellitus.
    Cameron OG; Kronfol Z; Greden JF; Carroll BJ
    Arch Gen Psychiatry; 1984 Nov; 41(11):1090-5. PubMed ID: 6497572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dexamethasone suppression test in patients with mood disorders.
    Rush AJ; Giles DE; Schlesser MA; Orsulak PJ; Parker CR; Weissenburger JE; Crowley GT; Khatami M; Vasavada N
    J Clin Psychiatry; 1996 Oct; 57(10):470-84. PubMed ID: 8909334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the dexamethasone suppression test in an inpatient setting: a replication and new findings.
    Maes M; De Ruyter M; Suy E
    Psychoneuroendocrinology; 1989; 14(3):231-9. PubMed ID: 2756075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships of the dexamethasone suppression test to clinical severity and degree of melancholia.
    Kumar A; Alcser K; Grunhaus L; Greden JF
    Biol Psychiatry; 1986 May; 21(5-6):436-44. PubMed ID: 3697434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The plasma dexamethasone window: evidence supporting its usefulness to validate dexamethasone suppression test results.
    O'Sullivan BT; Hunt GE; Johnson GF; Caterson ID
    Biol Psychiatry; 1989 Mar; 25(6):739-54. PubMed ID: 2923936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dexamethasone suppression test in adolescent outpatients with major depressive disorder.
    Birmaher B; Dahl RE; Ryan ND; Rabinovich H; Ambrosini P; al-Shabbout M; Novacenko H; Nelson B; Puig-Antich J
    Am J Psychiatry; 1992 Aug; 149(8):1040-5. PubMed ID: 1636803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative symptoms of schizophrenia and the dexamethasone suppression test.
    Garyfallos G; Lavrentiadis G; Amoutzias D; Monas K; Manos N
    Acta Psychiatr Scand; 1993 Dec; 88(6):425-8. PubMed ID: 8310850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexamethasone suppression test: use of two different dexamethasone doses.
    Hwang S; Zander J; Garvey M
    J Clin Psychiatry; 1984 Sep; 45(9):390-2. PubMed ID: 6469924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postdexamethasone plasma cortisol and beta-endorphin levels in depression: relationship to severity of illness.
    Meador-Woodruff JH; Haskett RF; Grunhaus L; Akil H; Watson SJ; Greden JF
    Biol Psychiatry; 1987 Sep; 22(9):1137-50. PubMed ID: 2958096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The DST in psychiatric outpatients with generalized anxiety disorder, panic disorder, or primary affective disorder.
    Avery DH; Osgood TB; Ishiki DM; Wilson LG; Kenny M; Dunner DL
    Am J Psychiatry; 1985 Jul; 142(7):844-8. PubMed ID: 4014507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dexamethasone suppression test in dementia: a review of the literature.
    Skare S; Pew B; Dysken M
    J Geriatr Psychiatry Neurol; 1990; 3(3):124-38. PubMed ID: 2282129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between depression and the dexamethasone suppression test following alcohol withdrawal in a psychiatric population.
    Johnson B; Perry JC
    J Clin Psychopharmacol; 1986 Dec; 6(6):343-9. PubMed ID: 3805327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dexamethasone suppression test in adolescent psychiatric patients.
    Ha H; Kaplan S; Foley C
    Am J Psychiatry; 1984 Mar; 141(3):421-3. PubMed ID: 6703110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The DST and its relationship to psychiatric diagnosis, symptoms and treatment outcome.
    Klein HE; Bender W; Mayr H; Niederschweiberer A; Schmauss M
    Br J Psychiatry; 1984 Dec; 145():591-9. PubMed ID: 6509268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dexamethasone suppression test in the clinical setting.
    Evans DL; Burnett GB; Nemeroff CB
    Am J Psychiatry; 1983 May; 140(5):586-9. PubMed ID: 6342422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The DST and posttraumatic stress disorder.
    Kudler H; Davidson J; Meador K; Lipper S; Ely T
    Am J Psychiatry; 1987 Aug; 144(8):1068-71. PubMed ID: 3605429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychopathological correlates of plasma cortisol after dexamethasone suppression: a polydiagnostic approach.
    Philipp M; Maier W; Holsboer F
    Psychoneuroendocrinology; 1986; 11(4):499-507. PubMed ID: 3562743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obsessive-compulsive disorder, depression, and the dexamethasone suppression test.
    Jenike MA; Baer L; Brotman AW; Goff DC; Minichiello WE; Regan NJ
    J Clin Psychopharmacol; 1987 Jun; 7(3):182-4. PubMed ID: 3597805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cortisol suppression per nanogram per milliliter of plasma dexamethasone in depressive and normal subjects.
    Carson SW; Halbreich U; Yeh CM; Asnis G; Goldstein S
    Biol Psychiatry; 1988 Sep; 24(5):569-77. PubMed ID: 3167145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.